GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » ROA %

Hisamitsu Pharmaceutical Co (TSE:4530) ROA % : 4.35% (As of Nov. 2023)


View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Hisamitsu Pharmaceutical Co's annualized Net Income for the quarter that ended in Nov. 2023 was 円14,772 Mil. Hisamitsu Pharmaceutical Co's average Total Assets over the quarter that ended in Nov. 2023 was 円339,605 Mil. Therefore, Hisamitsu Pharmaceutical Co's annualized ROA % for the quarter that ended in Nov. 2023 was 4.35%.

The historical rank and industry rank for Hisamitsu Pharmaceutical Co's ROA % or its related term are showing as below:

TSE:4530' s ROA % Range Over the Past 10 Years
Min: 3.05   Med: 6.22   Max: 7.24
Current: 4.25

During the past 13 years, Hisamitsu Pharmaceutical Co's highest ROA % was 7.24%. The lowest was 3.05%. And the median was 6.22%.

TSE:4530's ROA % is ranked better than
62.88% of 1083 companies
in the Drug Manufacturers industry
Industry Median: 1.54 vs TSE:4530: 4.25

Hisamitsu Pharmaceutical Co ROA % Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co ROA % Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.20 3.05 3.20 3.81 4.35

Hisamitsu Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.73 5.11 5.26 4.35 2.24

Competitive Comparison of Hisamitsu Pharmaceutical Co's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's ROA % distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's ROA % falls into.



Hisamitsu Pharmaceutical Co ROA % Calculation

Hisamitsu Pharmaceutical Co's annualized ROA % for the fiscal year that ended in Feb. 2024 is calculated as:

ROA %=Net Income (A: Feb. 2024 )/( (Total Assets (A: Feb. 2023 )+Total Assets (A: Feb. 2024 ))/ count )
=13969/( (313917+328779)/ 2 )
=13969/321348
=4.35 %

Hisamitsu Pharmaceutical Co's annualized ROA % for the quarter that ended in Nov. 2023 is calculated as:

ROA %=Net Income (Q: Nov. 2023 )/( (Total Assets (Q: Aug. 2023 )+Total Assets (Q: Nov. 2023 ))/ count )
=14772/( (344300+334909)/ 2 )
=14772/339604.5
=4.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Nov. 2023) net income data. ROA % is displayed in the 30-year financial page.


Hisamitsu Pharmaceutical Co  (TSE:4530) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Nov. 2023 )
=Net Income/Total Assets
=14772/339604.5
=(Net Income / Revenue)*(Revenue / Total Assets)
=(14772 / 143400)*(143400 / 339604.5)
=Net Margin %*Asset Turnover
=10.3 %*0.4223
=4.35 %

Note: The Net Income data used here is four times the quarterly (Nov. 2023) net income data. The Revenue data used here is four times the quarterly (Nov. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Hisamitsu Pharmaceutical Co ROA % Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines